12:00 AM
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AclarusDx: Pilot trial completed enrollment

Exonhit completed enrollment of 160 newly referred patients with memory impairment in a U.S. pilot trial evaluating AclarusDx....

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >